A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation

References

• WallMECamptothecin and taxol: discovery to clinicMed Res Rev19981852993149735871
   PubMed Web of Science ®Google Scholar
• ThomasCJRahierNJHechtSMCamptothecin: current perspectivesBioorg Med Chem20041271585160415028252
   PubMed Web of Science ®Google Scholar
• RothenbergMLTopoisomerase I inhibitors: review and updateAnn Oncol1997898378559358934
   PubMed Web of Science ®Google Scholar
• ZhangXChenBRecombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecinCancer Lett20102981263320579804
   PubMed Web of Science ®Google Scholar
• KratzFAbu AjajKWarneckeAAnticancer carrier-linked prodrugs in clinical trialsExpert Opin Investig Drugs200716710371058
   PubMed Web of Science ®Google Scholar
• ShiKTianYJiangYBWangLCuiFDModified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulationPharm Dev Technol201015664465219943738
   PubMed Web of Science ®Google Scholar
• ShiBFangCPeiYStealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activityJ Pharm Sci20069591873188716795003
   PubMedGoogle Scholar
• YangXLiLWangYTanYPreparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymersInt J Pharm20093701–221021519114094
   PubMed Web of Science ®Google Scholar
• ZhuHCaoJCuiSQianZGuYEnhanced tumor targeting and anti-tumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N′-octyl chitosan micellesJ Pharm Sci201310241318133223400693
   PubMed Web of Science ®Google Scholar
• ZhangCDingYYuLLPingQPolymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivativesColloids Surf B Biointerfaces200755219219917223019
   PubMed Web of Science ®Google Scholar
• HuWZhangCHuWJFangYHouWJPharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in miceFitoterapia20108371291129822858157
   PubMedGoogle Scholar
• LiYWeiPLiJLiLPharmacokinetic analysis and optimization of hydroxycamptothecin-loaded nanoparticles for liver targetingDrug Dev Ind Pharm201238783784722092005
   PubMed Web of Science ®Google Scholar
• YangLCuiFCunDTaoAShiKLinWPreparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticlesInt J Pharm20073401–216317217482779
   PubMed Web of Science ®Google Scholar
• WangHDFengJLLiuGJChenBJiangYXieQIn vitro and in vivo anti-tumor efficacy of 10-hydroxycamptothecin lymorphic nanoparticle dispersions: shape- and polymorph-dependent to toxicity and delivery of 10-hydroxycamptothecin to cancer cellsNanomedicine201612488189126767513
   PubMedGoogle Scholar
• SukJSXuQKimNHanesJEnsignLMPEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdv Drug Delivery Rev201699Pt A2851
   PubMed Web of Science ®Google Scholar
• DuJLiXZhaoHNanosuspensions of poorly water-soluble drugs prepared by bottom-up technologiesInt J Pharm2015495273874926383838
   PubMedGoogle Scholar
• ConstantinidesPPChaubalMVShorrRAdvances in lipid nanodispersions for parenteral drug delivery and targetingAdv Drug Deliv Rev200860675776718096269
   PubMed Web of Science ®Google Scholar
• PuXSunJWangYDevelopment of a chemically stable 10-hydroxycamptothecin nanosuspensionsInt J Pharm2009379116717319505545
   PubMed Web of Science ®Google Scholar
• KocbekPBaumgartnerSKristlJPreparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugsInt J Pharm20063121–217918616469459
   PubMed Web of Science ®Google Scholar
• JiangYBSunWLWangWRecrystallization and micronizat ion of 10-hydroxycamptothecin by supercritical antisolvent processInd Eng Chem Res20125125962602
   Google Scholar
• YangZGongWWangZA novel drug-polyethylene glycol liquid compound method to prepare 10-hydroxycamptothecin loaded human serum albumin nanoparticleInt J Pharm201549041242826027489
   PubMed Web of Science ®Google Scholar
• ZhaoYXHuaHYChangMLiuWJZhaoYLiuHMPreparation and cytotoxic activity of hydroxycamptothec in nanosuspensionsInt J Pharm2010392647120302926
   PubMed Web of Science ®Google Scholar
• LangerKBalthasarSVogelVDinauerNvon BriesenHSchubertDOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm20032571–216918012711172
   PubMed Web of Science ®Google Scholar
• WuGLaiRZhangZBThe research progress of poloxamer 188China Modern Doctor2008464849
   Google Scholar
• SanchezATobioMGonzalezLFabraAAlonsoMJBiodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-αEur J Pharm Sci2003183–422122912659933
   PubMed Web of Science ®Google Scholar
• ChenLWangYZhangJBexarotene nanocrystal-oral and parenteral formulation development, characterization and pharmacokinetic evaluationEur J Pharm Biopharm201487116016924333772
   PubMedGoogle Scholar
• ZakiNMAugmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipientsDrug Deliv201421426527524093513
   PubMed Web of Science ®Google Scholar
• AriasJLReddyLHCouvreurPPolymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabineJ Drug Target200917858659819694612
   PubMed Web of Science ®Google Scholar
• YangLJJiangJZHongJYHigh Drug Payload 10-Hydroxycamptothecin nanosuspensions stabilised by Cholesterol-PEG:In Vitro and In Vivo Investigation [J]J Biomed Nanotechnol2015111171172126310077
   PubMedGoogle Scholar
• ZhaoYXLiuDXLiangWQYeZWIn-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions [J]J Pharm Pharmacol201264678379122571256
   PubMedGoogle Scholar
• De JongWHHagensWIKrystekPBurgerMCSipsAJGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
   PubMed Web of Science ®Google Scholar
• KutscherHLChaoPDeshmukhMEnhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in ratsInt J Pharm20104021–2647120883756
   PubMedGoogle Scholar
• GiovanellaBCHinzHRKozielskiAJStehlinJSJrSilberRPotmesilMComplete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecinCancer Res19915111305230552032244
   PubMedGoogle Scholar